2026 MIPS Improvement Activity IA_BMH_2: Tobacco use
Written by Tucker Deyett, Dedicated Advisor, ReportingMD. Source data: CMS Quality Payment Program 2026 measure specifications and benchmark files.
Subcategory: Behavioral and Mental Health
At a glance
IA_BMH_2, Tobacco use, is a 2026 MIPS improvement activity in the Behavioral and Mental Health subcategory, included in 3 MVPs. For PY2026 activities are not weighted: clinicians with small practice, rural, non-patient-facing, or HPSA status attest to one activity, all other Traditional MIPS participants attest to two, and MVP participants attest to one.
Activity description
Tobacco use: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including tobacco use screening and cessation interventions (refer to NQF #0028) for patients with co-occurring conditions of behavioral or mental health and at risk factors for tobacco dependence.
Activity details
- Activity ID: IA_BMH_2
- Subcategory: Behavioral and Mental Health
- Programs: Traditional MIPS, APP, APP Plus
- First performance year: 2017
MVPs that include this activity
Advancing Rheumatology Patient Care; Patient Safety and Support of Positive Experiences with Anesthesia; Quality Care in Mental Health and Substance Use Disorders
Need help with IA_BMH_2?
ReportingMD is a CMS qualified registry and healthcare data pipe with a 100% submission rate since 2001. We confirm IA attestations and documentation with every client before submission. Talk to a ReportingMD advisor or browse the full 2026 MIPS directory.
